Finance

Beta
Lists
COSMO:BIT
Farmacosmo SpA
€0.38
-2.31%
(-0.0090) 1D
Jun 12, 5:26:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for COSMO...
Open
€0.39
High
€0.39
Low
€0.38
Mkt. cap
13.68M
Avg. vol.
22.93K
Volume
14.23K
52-wk high
€0.74
52-wk low
€0.38
EPS
-€0.11
No. of employees
87
Open
€0.39
High
€0.39
Low
€0.38
Mkt. cap
13.68M
Avg. vol.
22.93K
Volume
14.23K
52-wk high
€0.74
52-wk low
€0.38
EPS
-€0.11
No. of employees
87
News stories
From sources across the web
About Farmacosmo SpA
CEO-
Employees87
Founded2013
Headquarters-
SectorConsumer
Websitefarmacosmo.it
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
14.11M
14.11M
14.02M
14.02M
Cost of goods sold
14.34M
14.34M
15.11M
15.11M
Cost of revenue
14.34M
14.34M
15.11M
15.11M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
86.05K
86.05K
-86.05K
-86.05K
Operating expense
810.41K
810.41K
703.60K
703.60K
Total operating expenses
15.15M
15.15M
15.81M
15.81M
Operating income
-1.05M
-1.05M
-1.79M
-1.79M
Other non operating income
-
-
-612.40K
-612.40K
EBT including unusual items
-1.36M
-1.36M
-408.18K
-408.18K
EBT excluding unusual items
-1.36M
-1.36M
-408.18K
-408.18K
Income tax expense
94.67K
94.67K
436.46K
436.46K
Effective tax rate
-6.95%
-6.95%
-106.93%
-106.93%
Other operating expenses
75.63K
75.63K
114.93K
114.93K
Net income
-1.47M
-1.47M
-744.22K
-744.22K
Net profit margin
-10.43%
-10.43%
-5.31%
-5.31%
Earnings per share
-
-
-
-
Interest and investment income
2.59K
2.59K
1.99M
1.99M
Interest expense
-316.01K
-316.01K
-
-
Net interest expenses
-313.42K
-313.42K
1.99M
1.99M
Depreciation and amortization charges
15.93K
15.93K
16.92K
16.92K
EBITDA
-545.61K
-545.61K
-970.11K
-970.11K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer